Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic neuropsychological dimensions in schizophrenia.

Judith Jaeger1, Pál Czobor, Stefanie M Berns

  • 1Department of Psychiatric Rehabilitation, Center for Neuropsychiatric Outcome and Rehabilitation Research, Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY 11004, USA. jaeger@lij.edu

Schizophrenia Research
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

External Validation as the Critical Step for Predictive Biomarkers.

The international journal of neuropsychopharmacology·2026
Same author

The Clinically Meaningful Score Difference and Meaningful Score Regions in Positive and Negative Syndrome Scale Total Score from Post Hoc Analyses of a Phase 3 Pivotal Clinical Trial of Transdermal Asenapine in Patients with Schizophrenia.

Neuropsychiatric disease and treatment·2026
Same author

High-density EEG study in patients with schizophrenia treated with cariprazine.

The international journal of neuropsychopharmacology·2026
Same author

Disentangling violence in schizophrenia: Interactions between symptom trajectories, conduct disorder, and pharmacotherapy.

Schizophrenia research·2026
Same author

Letter to the Editor: Converging Approaches to Autistic Online Discourse.

Autism research : official journal of the International Society for Autism Research·2026
Same author

Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2025
Same journal

Quality evaluation of randomized controlled trials of antipsychotic drugs for schizophrenia published in Chinese journals.

Schizophrenia research·2026
Same journal

FL-SDGIN: A federated graph learning approach for schizophrenia diagnosis integrating static and dynamic brain functional networks.

Schizophrenia research·2026
Same journal

Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.

Schizophrenia research·2026
Same journal

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same journal

Inflammation-associated alterations in mGluR transcript expression in the human nucleus accumbens independent of schizophrenia diagnosis.

Schizophrenia research·2026
Same journal

One social interaction after another: Dynamic modeling of social experience in schizophrenia.

Schizophrenia research·2026
See all related articles

This study introduces a data-driven approach to neuropsychological (NP) assessment in schizophrenia, identifying stable neurocognitive factors. Findings challenge traditional domain groupings and highlight the need for refined NP measures in schizophrenia research.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Psychology

Background:

  • Neuropsychological (NP) studies in schizophrenia often use a priori domain groupings for data reduction, which may lack validity in schizophrenia samples.
  • Existing NP domain structures are often based on brain-injury models and may not accurately reflect cognitive functioning in schizophrenia.
  • Arbitrary selection of NP measures and potential lack of generalizability across samples and time points pose challenges in schizophrenia research.

Purpose of the Study:

  • To develop and validate a data-driven approach for identifying stable neurocognitive subdomains in schizophrenia using principal component analysis (PCA).
  • To assess the longitudinal stability of identified neurocognitive factors in a schizophrenia cohort.
  • To re-evaluate the validity of traditional NP domain structures and specific NP measures in the context of schizophrenia.

Related Experiment Videos

Main Methods:

  • Longitudinal study of 156 schizophrenia subjects with repeated NP testing at baseline, 6, and 18 months post-discharge.
  • A priori neurocognitive subdomains were grouped and analyzed using principal component analysis (PCA) at each time point.
  • Longitudinal stability of extracted factors was assessed using congruency coefficients.

Main Results:

  • Six stable neurocognitive factors were extracted, demonstrating good construct, divergent, and predictive validity.
  • Five frequently studied NP measures in schizophrenia did not correlate with these factors, suggesting their utility as independent subdomains.
  • Distinct factors for executive functioning, verbal memory, and motor functions could not be validated, questioning previous findings.

Conclusions:

  • The study provides a data-driven framework for understanding neurocognitive heterogeneity in schizophrenia, moving beyond traditional, potentially invalid, domain structures.
  • Findings suggest that certain NP measures should be considered independent neurocognitive subdomains rather than grouped into broader categories.
  • The lack of validation for executive functioning, verbal memory, and motor factors raises concerns about the interpretation of previous schizophrenia NP research.